MRK 3Q19 drug sales in China=$898M, +90%(!) YoY in constant currency: https://s21.q4cdn.com/488056881/files/doc_financials/2019/q3/3Q19-Earnings-Deck_MRK.pdf (slide #8) Given the looming price-cutting reported previously on this board, MRK's 3Q19 growth rate may be a high-water mark.